Pharmaceutical

MSD extends peptide collaboration with IRBM

IRBM has extended its collaboration with MSD to develop peptide therapeutics, following results in coronavirus, cholesterol, and obesity.

Jun 23, 2023 - 20:00
MSD extends peptide collaboration with IRBM
IRBM has extended its collaboration with MSD to develop peptide therapeutics, following results in coronavirus, cholesterol, and obesity.
Read the original article

Tags:

Previous Article

Intercept winds down NASH programme after FDA pulls plug on Ocaliva

Next Article

FDA approves Duchenne gene therapy with hefty $3.2m price tag

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: EQRx, failed developer of low-priced cancer drugs, is sold for cash

STAT+: EQRx, failed developer of low-priced cancer drug...

Aug 1, 2023

STAT+: Pharmalittle: We’re reading about Sanofi’s Olympics bet, Singulair problems, and more

STAT+: Pharmalittle: We’re reading about Sanofi’s Olymp...

Jan 10, 2024

STAT+: Cambridge announced as ‘investor catalyst’ hub for ARPA-H

STAT+: Cambridge announced as ‘investor catalyst’ hub f...

Sep 26, 2023